Atlas Trials

Lenalidomide With or Without Idelalisib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical trial NCT01838434 · COMPLETED

Trial details

NCT number
NCT01838434
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory Mantle Cell Lymphoma
Start date
2013-10-17
Primary completion
2014-09-30
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.